These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 24065118

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T, Hioki M, Fujiwara T, Nishizaki M, Kagawa S, Taki M, Kishimoto H, Endo Y, Urata Y, Tanaka N, Fujiwara T.
    Exp Cell Res; 2006 Feb 01; 312(3):256-65. PubMed ID: 16356494
    [Abstract] [Full Text] [Related]

  • 3. Telomerase-specific virotheranostics for human head and neck cancer.
    Kurihara Y, Watanabe Y, Onimatsu H, Kojima T, Shirota T, Hatori M, Liu D, Kyo S, Mizuguchi H, Urata Y, Shintani S, Fujiwara T.
    Clin Cancer Res; 2009 Apr 01; 15(7):2335-43. PubMed ID: 19318473
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Oncolytic virotherapy for human solid tumors].
    Fujiwara T.
    Gan To Kagaku Ryoho; 2009 May 01; 36(5):703-9. PubMed ID: 19461167
    [Abstract] [Full Text] [Related]

  • 6. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    Fujiwara T, Kagawa S, Kishimoto H, Endo Y, Hioki M, Ikeda Y, Sakai R, Urata Y, Tanaka N, Fujiwara T.
    Int J Cancer; 2006 Jul 15; 119(2):432-40. PubMed ID: 16477640
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T, Kawashima T, Kagawa S, Teraishi F, Taki M, Nishizaki M, Kyo S, Nagai K, Urata Y, Tanaka N, Fujiwara T.
    Cancer Res; 2004 Sep 01; 64(17):6259-65. PubMed ID: 15342413
    [Abstract] [Full Text] [Related]

  • 9. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, Wu M, Qian Q.
    Clin Cancer Res; 2006 Nov 01; 12(21):6523-31. PubMed ID: 17085667
    [Abstract] [Full Text] [Related]

  • 10. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').
    Taki M, Kagawa S, Nishizaki M, Mizuguchi H, Hayakawa T, Kyo S, Nagai K, Urata Y, Tanaka N, Fujiwara T.
    Oncogene; 2005 Apr 28; 24(19):3130-40. PubMed ID: 15735729
    [Abstract] [Full Text] [Related]

  • 11. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
    Watanabe Y, Hashimoto Y, Kagawa S, Kawamura H, Nagai K, Tanaka N, Urata Y, Fujiwara T.
    Cancer Gene Ther; 2012 Nov 28; 19(11):767-72. PubMed ID: 22956040
    [Abstract] [Full Text] [Related]

  • 12. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
    Fujiwara T, Tanaka N.
    Uirusu; 2008 Jun 28; 58(1):11-8. PubMed ID: 19122384
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N, Tsukuda M, Kimura M, Fujita K, Sakakibara A, Takahashi H, Ishiguro Y, Toth G, Matsuda H.
    Oncol Rep; 2010 Feb 28; 23(2):355-63. PubMed ID: 20043095
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents.
    Fujiwara T, Urata Y, Tanaka N.
    Front Biosci; 2008 Jan 01; 13():1881-6. PubMed ID: 17981675
    [Abstract] [Full Text] [Related]

  • 15. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H, Wei F, Li H, Ji X, Li S, Chen X.
    Int J Mol Med; 2013 Feb 01; 31(2):377-85. PubMed ID: 23229955
    [Abstract] [Full Text] [Related]

  • 16. In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy.
    Kojima T, Watanabe Y, Hashimoto Y, Kuroda S, Yamasaki Y, Yano S, Ouchi M, Tazawa H, Uno F, Kagawa S, Kyo S, Mizuguchi H, Urata Y, Tanaka N, Fujiwara T.
    Ann Surg; 2010 Jun 01; 251(6):1079-86. PubMed ID: 20485131
    [Abstract] [Full Text] [Related]

  • 17. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
    Takakura M, Nakamura M, Kyo S, Hashimoto M, Mori N, Ikoma T, Mizumoto Y, Fujiwara T, Urata Y, Inoue M.
    Cancer Gene Ther; 2010 Jan 01; 17(1):11-9. PubMed ID: 19662088
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y, Zhu Y, Huang X, Ai K, Zheng Q, Yuan Z.
    Int J Oncol; 2015 Aug 01; 47(2):668-78. PubMed ID: 26081241
    [Abstract] [Full Text] [Related]

  • 19. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
    Lanson NA, Friedlander PL, Schwarzenberger P, Kolls JK, Wang G.
    Cancer Res; 2003 Nov 15; 63(22):7936-41. PubMed ID: 14633724
    [Abstract] [Full Text] [Related]

  • 20. A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.
    Sasaki T, Tazawa H, Hasei J, Osaki S, Kunisada T, Yoshida A, Hashimoto Y, Yano S, Yoshida R, Kagawa S, Uno F, Urata Y, Ozaki T, Fujiwara T.
    Gene Ther; 2013 Jan 15; 20(1):112-8. PubMed ID: 22241176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.